ResMed Inc.

RMD·NYSE·Healthcare
Compare
234.60+4.55 (+1.98%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours234.600.00 (0.00%)Oct 12, 6:04 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close230.05
Open231.74
Day range230.08235.98
52-week range180.27277.67
Off day high−0.58%
Off 52-week high−15.51%
Volume1.02M
Avg. volume (3M)1.32M
Market cap32.99B
EPS (TTM)10.43
Forward P/E17.73
P/E ratio (TTM)22.49
Dividend yield1.15% (2.64)
Beta (5Y)0.75
Shares outstanding140.64M
Short interest10.52% of float
Earnings dateOct 29, 2026
Analyst target250.22
Profit margin26.95%

Against its peers

Compare in full ›
RMD KMTS ISRG MMSI MMED TFX
Market cap 32.99B 1.60B 151.08B 5.36B 5.29B 5.33B
P/E (TTM) 22.5 — 49.0 36.9 — —
Forward P/E 17.7 -13.1 35.3 19.5 29.5 11.5
Price/book 5.1 7.2 8.3 3.2 1.5 1.8
Dividend yield 1.15% — — — — 1.09%
1-year change −15.74% +19.49% −2.01% +9.79% +6.60% +4.19%
Today +1.98% −0.26% +0.87% +2.91% −4.62% +0.46%

The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.

Latest news

All RMD news ›
The Motley Fool Australia·

Buy, hold, sell: Resmed, Megaport, ANZ shares

Let's start the week with some fresh ratings from the experts. S&P/ASX 200 Index (ASX: XJO) shares rose 0.4% last week and are down almost 2% over 12 months. Let's start the new week with some fresh ratings from the experts (courtesy The…

@kalkineau·

Is ResMed Facing Fresh Questions Before Results (ASX:RMD)?

ASX Rallies as Banks and BHP Shine, Telcos Slide on SpaceX Fear The company confirmed at the start of the month that it will release its first-quarter fiscal results at the end of October. The release will be the first full set of numbers…

Defense World·Negative

ResMed (NYSE:RMD) CEO Sells $1,129,613.03 in Stock

Posted by Defense World Staff on Oct 11th, 2026 Read Our Latest Stock Report on RMD ResMed Inc (NYSE: RMD) develops, manufactures and distributes medical equipment and digital health solutions for sleep apnea, chronic obstructive pulmonary…

@kalkineau·Positive

Why Is ResMed (ASX:RMD) Leaning on Capital Returns?

Is Light & Wonder (ASX:LNW) Winning Floor Space After Vegas? Can Catapult Sports (ASX:CAT) Rebuild Momentum After Its Slide? Can WebBeds Group (ASX:WEB) Keep Growing as Shares Lag? Will Tyro Payments (ASX:TYR) Gain From the Surcharge Ban?…

StockStory·Negative

ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?

ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 15.9% gain during that period. Is now the time to buy RMD? Or does…

Markets Daily·Positive

Brainsway (NASDAQ:BWAY) & ResMed (NYSE:RMD) Head-To-Head Review

Posted by Danessa Lincoln on Oct 5th, 2026 Brainsway (NASDAQ:BWAY – Get Free Report) and ResMed (NYSE:RMD – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on…

From articles in the 4Search news index.

In the news

31mentions in 30 days
22with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.